Diaverum to present at EDTNA/ERCA International Conference 2013

Report this content

Corporate Education Session about innovations in vascular access

Munich / Malmö, 30 August 2013 — Diaverum, one of the world’s leading renal care providers, is hosting a Corporate Education Session at the 42nd EDTNA/ERCA International Conference 2013 in Malmö, Sweden. The session is entitled “Innovations in vascular access – reducing risk, promoting quality, improving care” and will discuss how to reduce the risk of venous needle dislodgement, the role of vascular access nurses to promote quality and how to improve care by implementation of buttonhole cannulation.

“Vascular access is often referred to as the lifeline for dialysis patients. Therefore taking proper care of vascular access is a critical factor in patient well-being and survival,” says Jan Cowperthwaite, Corporate Director of Clinical Education at Diaverum.

“We believe that the nurses play a vital role in the care of vascular access and thus can be significant drivers for innovations. By sharing our best practices and study results at this year’s EDTNA/ERCA, we want to support others to improve the care they give,” explains Jan Cowperthwaite.

“The aim of Diaverum is to constantly raise the level of quality in the care that we deliver and to generate the best possible medical outcome for all our patients. Developing new methods and creating innovations in vascular access is an essential part of this approach,” comments Dr. Jörgen Hegbrant, Chief Medical Officer at Diaverum.

In the Corporate Education Session at EDTNA/ERCA 2013, the Diaverum country clinical specialists and lead nurses will speak about reducing the risk of venous needle dislodgement, the role of vascular access nurses in promoting quality and improving care by the implementation of buttonhole cannulation. “We are very keen on investigating and further enhancing buttonhole cannulation, because it improves the patient experience by reducing pain and bleeding”, says Jan Cowperthwaite.

In addition, Diaverum is presenting itself in the exhibition area on the first floor, booth no 6. Interested nurses and medical staff can receive information about Diaverum as an employer and the Diaverum “touch that makes the difference”.

The 42nd EDTNA/ERCA International Conference will run from Saturday, 31 August, until Tuesday, 3 September, in Malmö, Sweden. This year’s conference theme is ‘Innovation of renal care through multi-professional leadership’. The Diaverum Corporate Education Session takes place on Sunday, 1 September 2013 at 14.00 in the Concert Hall of the Congress Centre. The full agenda and programme can be found at http://www.edtna-erca-conference2013.com/s12-diaverum.htm.

The EDTNA/ERCA International Conference brings together an international mix of renal professionals, industry partners, national association representatives and universities. Diaverum has been a partner of the conference for many years. Industry symposia and industry-supported sessions, such as the Diaverum Corporate Education Session, are a key part of the Conference Scientific Programme.

Press Contact
Christine Buchberger
Manager External Communication
Diaverum
E-mail: Christine.buchberger@diaverum.com
Phone: +49/89-452444139

About Diaverum
At Diaverum, our mission is to improve the quality of life for renal patients by revitalising them both physically and emotionally. Being one of the world’s leading renal care providers, Diaverum offers a holistic approach, from preventive and early stage renal care to all renal replacement therapies. As a product independent provider — the largest in Europe — we are able to focus solely on caring for the individual needs of our patients. Our experience in renal care dates back 20 years, when the first dialysis clinic was established, previously under our former name Gambro Healthcare. Today, 7,100 employees care for almost 22,000 patients in 18 countries in Europe, Latin America, Middle East and Australia. Diaverum has its roots in Lund, Sweden and a corporate office located in Munich, Germany. For more information visit: www.diaverum.com.

Subscribe

Documents & Links